2Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing :practical aspects and current challenges.Clin Microbiol Rev,2001,14:643-658.
3Verweij PE, Van den Bergh MF, Rath PM, et al. Invasive aspergillosisi caused by aspergillus ustus:case report and review.Clin Microbiol,1999,37:1606-1609.
4Moore CB,Walls CM,Denning DW.In vitro activities of terbinafine against aspergillus species in comparison with those of itraconazole and amphotericin B.Antimicrob Agents Chemother,2001,45:1882-1885.
5Te Dorsthorst DT,Verweij PE,Meis JF,et al.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole -susceptible and resistant aspergillus fumigatus isolates.Antimicrob Agents Chemother,2002, 46:702-707.
6Ryder NS, Leitner L. Synergistic interaction of terbinaflne with triazoles or amphotericin B against Aspergillus species.Med Mycol,2001,39:91-95.
7Barchiesi F, Falconi DiFrancesco L, Scalise G, et al. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoes.Antimicrob Agents Chemother, 1997,41:1812-1814.
8Kontoyiannis P, Lewis RE, Sagar N, et al. Itraconazole-amphotericin B antagonism in Aspergillus fumigatus:an E-test -based strategy .Antimicrob Agents Chemother ,2000,44:2915-2918.
9Mosquera J, Sharp A, Moore CB, et al. In vitro interaction of terbinafine with itraconazole, fluconazole ,amphotericin B and 5-flucytosine against Aspergillus spp.Antimicrob Chemother , 2002,50 : 189-194.
10Nguyen MH, Barchiesi F,McGough DA, et al. In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var neofomans.Antimicrob Agents Chemother , 1995,39 :1691-1695.
